Literature DB >> 780099

Calcium antagonists and islet function. II. Interaction of theophylline and verapamil.

G Somers, G Devis, E Van Obberghen, W J Malaisse.   

Abstract

Verapamil inhibits glucose-induced insulin release by the isolated perfused rat pancreas. The dose-response relationship for the inhibitory action of verapamil is shifted to higher concentrations of the drug when the concentration of calcium in the perfusate is increased. The degree of inhibition of glucose-induced insulin release by a given concentration of verapamil decreases as the length of exposure to glucose is increased prior to introduction of the calcium antagonist. Theophylline augments glucose-stimulated insulin release and protects the beta-cell against the inhibitory action of verapamil, both effects of theophylline being dose-related. Even after pretreatment of the pancreas with a high concentration of verapamil, theophylline is able, in the presence of glucose, to stimulate insulin release and, eventually, to restore a nearly normal secretory response to this sugar. We suggest that theophylline, by mobilizing calcium from an organelle-bound pool within the beta-cell, compensates for the verapamil-induced reduction in calcium inward transport into the beta-cell.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 780099     DOI: 10.1210/endo-99-1-114

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  10 in total

1.  The stimulus-secretion coupling of glucose-induced insulin release. Metabolic and functional effects of NH4+ in rat islets.

Authors:  A Sener; J C Hutton; S Kawazu; A C Boschero; G Somers; G Devis; A Herchuelz; W J Malaisse
Journal:  J Clin Invest       Date:  1978-10       Impact factor: 14.808

2.  Protective effect of calcium against the verapamil-induced inhibition of ionophore-mediated calcium translocation.

Authors:  W J Malaisse
Journal:  Experientia       Date:  1979-12-15

3.  Inhibition by isoptin (a calcium antagonist) of the mitogenic stimulation of lymphocytes prior to the S-phase.

Authors:  E Blitstein-Willinger; T Diamantstein
Journal:  Immunology       Date:  1978-02       Impact factor: 7.397

4.  Abnormal regulation of insulin secretion in the genetically obese (ob/ob) mouse.

Authors:  M Black; H M Heick; N Bégin-Heick
Journal:  Biochem J       Date:  1986-09-15       Impact factor: 3.857

5.  Inhibition of rat mast cell degranulation by verapamil.

Authors:  A Legrand; J Cerrina; C Bonne; A Lockhart; J Benveniste
Journal:  Agents Actions       Date:  1984-02

6.  The stimulus-secretion coupling of glucose-induced insulin release. Insulin release due to glycogenolysis in glucose-deprived islets.

Authors:  W J Malaisse; A Sener; M Koser; M Ravazzola; F Malaisse-Lagae
Journal:  Biochem J       Date:  1977-05-15       Impact factor: 3.857

7.  Calcium antagonists and islet function. IX. Is extracellular calcium required for insulin release?

Authors:  G Somers; G Devis; W J Malaisse
Journal:  Acta Diabetol Lat       Date:  1979 Jan-Mar

8.  Inhibition by verapamil of ionophore-mediated calcium translocation.

Authors:  W J Malaisse; G Devis; G Somers
Journal:  Experientia       Date:  1977-08-15

9.  Impairment of insulin secretion in man by nifedipine.

Authors:  D Giugliano; R Torella; F Cacciapuoti; S Gentile; M Verza; M Varricchio
Journal:  Eur J Clin Pharmacol       Date:  1980-11       Impact factor: 2.953

10.  Dependency of cyclic AMP-induced insulin release on intra- and extracellular calcium in rat islets of Langerhans.

Authors:  E G Siegel; C B Wollheim; M Kikuchi; A E Renold; G W Sharp
Journal:  J Clin Invest       Date:  1980-02       Impact factor: 14.808

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.